Orexo AB (ORX) - Total Liabilities

Latest as of December 2025: Skr812.20 Million SEK ≈ $87.41 Million USD

Based on the latest financial reports, Orexo AB (ORX) has total liabilities worth Skr812.20 Million SEK (≈ $87.41 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ORX cash flow metrics to assess how effectively this company generates cash.

Orexo AB - Total Liabilities Trend (2002–2025)

This chart illustrates how Orexo AB's total liabilities have evolved over time, based on quarterly financial data. Check Orexo AB liquidity resilience to evaluate the company's liquid asset resilience ratio.

Orexo AB Competitors by Total Liabilities

The table below lists competitors of Orexo AB ranked by their total liabilities.

Company	Country	Total Liabilities
Kamdhenu Limited NSE:KAMDHENU	India	Rs618.81 Million
Huikwang TWO:6508	Taiwan	NT$378.89 Million
Sekar Bumi Tbk JK:SKBM	Indonesia	Rp1.06 Trillion
Dynamic Medical Technologies TWO:4138	Taiwan	NT$1.23 Billion
Island Pharmaceuticals Ltd AU:ILA	Australia	AU$336.43K
Oswal Agro Mills Limited NSE:OSWALAGRO	India	Rs58.98 Million
Gateway Real Estate AG XETRA:GTY	Germany	€1.18 Billion
FALCON METALS LTD F:E47	Germany	€883.21K

Liability Composition Analysis (2002–2025)

This chart breaks down Orexo AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Orexo AB market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.70	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.66	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.62	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Orexo AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Orexo AB (2002–2025)

The table below shows the annual total liabilities of Orexo AB from 2002 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr812.20 Million ≈ $87.41 Million	+12.63%
2024-12-31	Skr721.10 Million ≈ $77.60 Million	-0.91%
2023-12-31	Skr727.70 Million ≈ $78.31 Million	-20.48%
2022-12-31	Skr915.10 Million ≈ $98.48 Million	-0.97%
2021-12-31	Skr924.10 Million ≈ $99.45 Million	+37.03%
2020-12-31	Skr674.40 Million ≈ $72.58 Million	-15.14%
2019-12-31	Skr794.70 Million ≈ $85.52 Million	-1.96%
2018-12-31	Skr810.60 Million ≈ $87.23 Million	+20.12%
2017-12-31	Skr674.80 Million ≈ $72.62 Million	-4.76%
2016-12-31	Skr708.50 Million ≈ $76.25 Million	-5.51%
2015-12-31	Skr749.85 Million ≈ $80.70 Million	-2.73%
2014-12-31	Skr770.86 Million ≈ $82.96 Million	+26.19%
2013-12-31	Skr610.87 Million ≈ $65.74 Million	+110.24%
2012-12-31	Skr290.56 Million ≈ $31.27 Million	+23.64%
2011-12-31	Skr235.00 Million ≈ $25.29 Million	-3.87%
2010-12-31	Skr244.45 Million ≈ $26.31 Million	+142.82%
2009-12-31	Skr100.67 Million ≈ $10.83 Million	-23.87%
2008-12-31	Skr132.24 Million ≈ $14.23 Million	+1.24%
2007-12-31	Skr130.62 Million ≈ $14.06 Million	+135.01%
2006-12-31	Skr55.58 Million ≈ $5.98 Million	+71.54%
2005-12-31	Skr32.40 Million ≈ $3.49 Million	+21.90%
2004-12-31	Skr26.58 Million ≈ $2.86 Million	+186.74%
2003-12-31	Skr9.27 Million ≈ $997.60K	+19.91%
2002-12-31	Skr7.73 Million ≈ $831.98K	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$70.45 Million

Skr654.63 Million SEK

Market Cap Rank

#20535 Global

#367 in Sweden

Share Price

Skr18.86

Change (1 day)

-0.32%

52-Week Range

Skr13.80 - Skr41.60

All Time High

Skr85.70